Announcement PDF RNS Number : 2405X Valereum PLC 14 February 2025 14/02/2025 Valereum Plc ("Valereum", "VLRM" or the "Company") Valereum PLC Update on Blue Sky Vision Option Exercise Valereum Plc (AQSE: VLRM) would like to inform the market that the £2 million option agreement with Blue Sky Vision LLC (announced on 16 December 2024 and on 2 January 2025) will not be proceeding. However, Valereum Plc is in negotiations with another entity to take up this subscription as part of the wider ongoing discussions previously announced to the market and expect to come to a satisfactory conclusion during February. There is no guarantee that Valereum Plc will successfully close the proposed £2 million raise and further market updates will be provided in due course. For more information, and the chance to have your questions directly answered by the management team, please head to our interactive investor hub via:Investor Hub. Here you will find all company news and additional content to further explain Valereum's strategy and products. For further information, please contact: Valereum Plc Peter Sekhon, Investor Relation Director Engage with the company directly Tel: +44 7938 767319 Investor Hub Stanford Capital Partners Bob Pountney/ Patrick Claridge Tel: +44 023 3650 3650 AQSE Corporate Adviser First Sentinel Corporate Finance Brian Stockbridge / Gabrielle Cordeiro Tel: +44 20 3855 5551 The Directors of the Company accept responsibility for the contents of this announcement. For more information, please visit the Company's website atwww.vlrm.com or to engage with the Valereum management team directly by asking questions, watching video summaries and seeing what other shareholders have to say. Navigate to our Interactive Investor hub here:Sign Up This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END NEXGPUQPPUPAGQC